Inhibition of hedgehog signalling attenuates <scp>UVB</scp>‐induced skin photoageing

  • Wanyeon Kim
    Department of Biological Sciences Pusan National University Busan South Korea
  • EunGi Kim
    Department of Integrated Biological Science Pusan National University Busan South Korea
  • Hee Jung Yang
    Department of Biological Sciences Pusan National University Busan South Korea
  • TaeWoo Kwon
    Department of Integrated Biological Science Pusan National University Busan South Korea
  • SeoYoung Han
    Department of Integrated Biological Science Pusan National University Busan South Korea
  • Sungmin Lee
    Department of Integrated Biological Science Pusan National University Busan South Korea
  • HyeSook Youn
    Department of Biological Sciences Pusan National University Busan South Korea
  • Youngmi Jung
    Department of Biological Sciences Pusan National University Busan South Korea
  • ChulHee Kang
    Department of Chemistry Washington State University Pullman Washington USA
  • BuHyun Youn
    Department of Biological Sciences Pusan National University Busan South Korea

書誌事項

公開日
2015-05-26
権利情報
  • http://onlinelibrary.wiley.com/termsAndConditions#vor
DOI
  • 10.1111/exd.12735
公開者
Wiley

この論文をさがす

説明

<jats:title>Abstract</jats:title><jats:p>The hedgehog (Hh) signalling pathway regulates normal development and cell proliferation in metazoan organisms, but its aberrant activation can promote tumorigenesis and progression of a variety of aggressive human cancers including skin cancer. Despite its importance, little is known about its role in photoageing, a type of <jats:styled-content style="fixed-case">UV</jats:styled-content>‐induced skin lesions. In this study, we investigated the involvement of Hh signalling in the photoageing process as well as the use of an Hh‐regulating alkaloid compound as a novel therapeutic drug to regulate photoageing in keratinocytes. We found that <jats:styled-content style="fixed-case">UVB</jats:styled-content> induced Hh signalling by the expression of Hh ligands and Hh‐mediated transcription factors, respectively. Moreover, <jats:styled-content style="fixed-case">UVB</jats:styled-content>‐induced Hh activation relied on mitogen‐activated protein kinase (p38, <jats:styled-content style="fixed-case">ERK</jats:styled-content> and <jats:styled-content style="fixed-case">JNK</jats:styled-content>) activity and inflammatory responses (upregulation of <jats:styled-content style="fixed-case">COX</jats:styled-content>‐2, <jats:styled-content style="fixed-case">IL</jats:styled-content>‐1<jats:italic>β</jats:italic>,<jats:styled-content style="fixed-case"> IL</jats:styled-content>‐6 and <jats:styled-content style="fixed-case">TNF</jats:styled-content>‐<jats:italic>α</jats:italic>), resulting in premature senescence and photoageing <jats:italic>in vitro</jats:italic> and <jats:italic>in vivo</jats:italic>. Notably, a selected Hh inhibitor, evodiamine, mediated photoageing blockade in a mouse skin model. Taken together, our findings demonstrated that Hh signalling is associated with <jats:styled-content style="fixed-case">UVB</jats:styled-content>‐induced photoageing, while pharmacological inhibition of Hh signalling significantly reduced experimental photoageing, indicating its potential for use as a therapeutic target for this disease.</jats:p>

収録刊行物

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ